These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 17651259

  • 1. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
    Chilov MN, Grigg JR, Playfair TJ.
    Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
    [Abstract] [Full Text] [Related]

  • 2. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
    Mason JO, Albert MA, Mays A, Vail R.
    Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
    [No Abstract] [Full Text] [Related]

  • 3. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R, Kulkarni A, Franks WA.
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract] [Full Text] [Related]

  • 4. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU.
    Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
    [No Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S, Hendi K, Pakravan M.
    J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
    [Abstract] [Full Text] [Related]

  • 7. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
    Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S.
    Eur J Ophthalmol; 2008 Aug; 18(2):255-62. PubMed ID: 18320519
    [Abstract] [Full Text] [Related]

  • 8. Bevacizumab in glaucoma: a review.
    Ichhpujani P, Ramasubramanian A, Kaushik S, Pandav SS.
    Can J Ophthalmol; 2007 Dec; 42(6):812-5. PubMed ID: 18026201
    [Abstract] [Full Text] [Related]

  • 9. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F, Astam N, Ozmert E.
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [Abstract] [Full Text] [Related]

  • 10. Topical bevacizumab for neovascular glaucoma: a pilot study.
    Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I.
    Pharmacology; 2014 Feb; 93(3-4):108-12. PubMed ID: 24556733
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY, Schuman JS, Noecker RJ.
    Ophthalmic Surg Lasers Imaging; 2006 Feb; 37(2):144-6. PubMed ID: 16583637
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A, Spratt A, Ogunbowale L, dell'Omo R, Kulkarni A, Bunce C, Franks WA.
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [Abstract] [Full Text] [Related]

  • 13. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S, Buchacra O, Milla E, Andreu D, Tellez J.
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
    Lupinacci AP, Calzada JI, Rafieetery M, Charles S, Netland PA.
    Adv Ther; 2009 Feb; 26(2):208-16. PubMed ID: 19234680
    [Abstract] [Full Text] [Related]

  • 15. Intracameral bevacizumab for iris rubeosis.
    Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group.
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [Abstract] [Full Text] [Related]

  • 16. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
    Shin JP, Lee JW, Sohn BJ, Kim HK, Kim SY.
    J Glaucoma; 2009 Jul; 18(8):589-94. PubMed ID: 19826387
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
    Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM.
    Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
    Sasamoto Y, Oshima Y, Miki A, Wakabayashi T, Song D, Matsushita K, Hamasaki T, Nishida K.
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
    Vatavuk Z, Bencic G, Mandic Z.
    Eur J Ophthalmol; 2007 Feb; 17(2):269-71. PubMed ID: 17415704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.